Active Cancer Infection & Immunity

PI3K in cancer biology and therapy

Funder CRUK Charity-funded
Recipient organisation University College London
Funding Not disclosed
Period Apr 2025 — Mar 2030

About this grant

This summary is based on the grant title only — the full abstract was not available.

Research project funded by CRUK at University College London.

View the original record at the funder ↗

Researchers

Bart Vanhaesebroeck (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

PI3Kalpha and PI3Kdelta in cancer biology and therapy
Dissection of phosphoinositide metabolism and identification of novel therapeutic targets in cancer using cell models with genetic inactivation of multiple PI 3-kinases
PI 3-kinase isoforms in cancer
New signalling mechanisms of pi 3-kinase
Class IA PI 3-kinase isoforms in oncogenic signalling

Original classification

Discovery Research Committee - Programme

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.